Beta Drugs Limited — Dividend/Bonus, 05-02-2025: Bonus

The Board of Beta Drugs Limited has approved a bonus issue of shares in a 1:20 ratio, offering 1 new fully paid-up equity share of Rs. 10 each for every 20 existing shares held as of a record date to be declared later. The bonus shares will be issued from the company’s Securities Premium Account, with an approximate total of 5,16,076 shares amounting to Rs. 51.61 lakh. Additionally, the board approved an increase in authorized share capital from Rs. 10.50 crore to Rs. 11 crore, appointing two additional independent directors and noting the resignation of a whole time director. The bonus shares are expected to be credited within two months following shareholder approval.